SIM
WINT

Spark Investment Management’s Windtree Therapeutics Inc WINT Stock Holding History

Spark Investment Management’s Portfolio WINT Stock Details WINT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-1,879
Closed -$17K – 819
2015
Q2 		$17K Buy
+1,879
New +$26.4K ﹤0.01% 654

Other funds holding WINT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Spark Investment Management's WINT Position: Q3 2015 in Review

Spark Investment Management sold out of Windtree Therapeutics Inc (WINT) in Q3 2015, closing a stake of 1,879 shares — an estimated $17K sold.

Spark Investment Management first reported a position in WINT in Q2 2015 and held it in 1 quarter. The position peaked at $17K in Q2 2015. 48 funds tracked by Wall St. Rank hold WINT as of Q3 2015.

  • Spark Investment Management reported no remaining Windtree Therapeutics Inc position as of Q3 2015 after selling out during the quarter.
  • Spark Investment Management sold 1,879 Windtree Therapeutics Inc shares in Q3 2015, an estimated $17K.
  • Spark Investment Management first reported a position in Windtree Therapeutics Inc in Q2 2015 and held it in 1 quarter.
  • Spark Investment Management's Windtree Therapeutics Inc position peaked at $17K in Q2 2015.
  • 48 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q3 2015.

Based on Spark Investment Management's 13F filing for Q3 2015, filed 12 Nov 2015.